Sachiko Ando

Discontinuation of dasatinib in patients with chronic myeloid leukaemia who have maintained deep molecular response for longer than 1 year (DADI trial): a multicentre phase 2 trial

Jun Imagawa, Hideo Tanaka, Masaya Okada et al. · The Lancet Haematology · 2015 · 297 citations

Hematological Malignancy, Medicine, Chronic Myeloid Leukaemia +11

Final 3-year Results of the Dasatinib Discontinuation Trial in Patients With Chronic Myeloid Leukemia Who Received Dasatinib as a Second-line Treatment

Masaya Okada, Jun Imagawa, Hideo Tanaka et al. · Clinical Lymphoma Myeloma & Leukemia · 2018 · 116 citations · Full text

Constitutional trisomy 8 mosaicism with myelodysplastic syndrome complicated by intestinal Behcet disease and antithrombin III deficiency

Sachiko Ando, Masayo Maemori, Hajime Sakai et al. · Cancer Genetics and Cytogenetics · 2005 · 34 citations

Myelodysplastic Syndrome, Autoimmune Disease, Immunology +9

TAFRO syndrome showing cholangitis on liver biopsy.

Yuki Nagai, Sachiko Ando, N. Honda et al. · PubMed · 2016 · 14 citations

Renal Pathology, Immunology, Diagnosis +24

Successful Reduced-Intensity Stem Cell Transplantation with Cord Blood for a Poor-Prognosis Adult with Refractory Chronic Active Epstein-Barr Virus Infection

Masao Nakagawa, Satoshi Hashino, Mutsumi Takahata et al. · International Journal of Hematology · 2007 · 10 citations

Cell Therapy, Transplantation, Marrow Transplantation +8